Anteris Technologies Global Corp. Rings the Nasdaq Stock Market Opening Bell

Anteris Technologies Global Corp.(“Anteris”) (Nasdaq: AVR), a global structural heart company dedicated to revolutionizing cardiac care visits the Nasdaq MarketSite in Times Square to celebrate the Company’s official listing on Nasdaq. Anteris is now dual listed (Nasdaq: AVR, ASX: AVR) representing a significant milestone in the Company’s journey and ongoing commitment to restore heart valve patients to healthy function.

Inspired by nature and guided by the scientific process, Anteris has taken a paradigm-shifting approach to disrupt the impact of valve disease on the whole heart by creating the first-in-class biomimetic DurAVR® Transcatheter Heart Valve (THV). This cutting-edge valve, incorporating the Company’s proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.

In honor of the occasion, Wayne Paterson, Chief Executive Officer, rings the Opening Bell.